To extend our knowledge of the excision repair system in mammalian cells we have focussed on the isolation of genes and proteins involved in this process. For the purification and characterization of human repair proteins the microneedle injection assay technique is utilized. This system is based on the transient correction of the excision repair defect of xeroderma pigmentosum (XP) fibroblasts (scored as increase of ultraviolet (u.v.)-induced unscheduled DNA synthesis (U D S )) upon microinjection of crude extracts from complementing XP or normal cells. Specific correction is observed in fibroblasts of all (9) excision-deficient XP complementation groups. The XP-A and G correcting factors were found to be proteins and several purification steps (including (N H^S C^ fractionation, chromatography of phosphocellulose, heparin and u.v.-irradiated DNA-cellulose) have been worked out for the XP-A correcting protein.
INTRODUCTION
The implication of DNA repair systems in vital processes such as mutagenesis, carcinogenesis and maintenance of primary DNA structure stresses the importance of investigating how these systems operate at the molecular level. Availability of genes and proteins involved in DNA repair is of basic interest to such studies. The isolation of genes, and subsequent purification of the products, functioning in repair systems of Escherichia coli (particularly in the excision repair pathway and the removal of alkylation lesions) has led to a considerable extension of our knowledge about mechanisms and genetic control of these processes in prokaryotes (Walker, 1985; Teo et al. 1986 ; for an extensive review on D NA repair in general, see Friedberg, 1985) . For lower eukaryotes the phase of cloning repair genes has been reached with the recent isolation of a series of genes involved in three major repair pathways in the yeast Saccharomyces cerevisiae (e.g. see Yasui & Chevallier, 1983; Adzuma et al. 1984; Naumovski et al. 1985; Nicolet et al. 1985; Reynolds et al. 1985a ,b\ Perozzi & Prakash, 1986 . As far as higher eukaryotes are concerned, valuable tools for the isolation of repair genes and proteins are available in the form of naturally occurring and laboratory-induced mutant cells. These are mainly of human and rodent origin. The most extensively characterized class of mutants is disturbed in the excision repair process, one of the major repair systems in the cell. Fibroblasts from many patients suffering from the autosomal recessive human syndrome xeroderma pigmentosum (XP) fall into this category (Cleaver, 1968) . Genetic studies involving cell hybridization have disclosed the existence of nine complementation groups within the excision-deficient class of XP individuals (de Weerd-Kastelein et al. 1972; Fischer et al. 1985) and at least five within excisiondeficient mutants generated from Chinese hamster ovary (CHO) cells (Thompson et al. 1981 (Thompson et al. , 1982 Thompson & Carrano, 1983) . It is not known whether some of these complementation groups are the same in both species; however, none of the mutants is able to perform efficiently the first step postulated in the excision pathway, i.e. the incision of the damaged DNA strand at or near the photolesion. This suggests the participation of at least nine, and possibly more than 13, genes and proteins in nucleotide excision. T o date, progress with regard to the isolation of the components involved is limited, due to the complexity of the system and the experimental limitations of the organisms. Recently, we have cloned the first human gene (designated ERCC-1), implicated in the excision of lesions induced by ultraviolet (u.v.) light and cross-linking agents (Westerveld et al. 1984) . Using microneedle injection we are in the process of purifying and characterizing proteins deficient in XP. Furthermore, we are investigating whether well-characterized repair proteins of heterologous organisms can interact with mammalian repair systems. In this chapter we will summarize results obtained on these topics. Part of the work reviewed here has been published in detail elsewhere (de Jonge et al. 1983 (de Jonge et al. , 1985 Zwetsloot et al. 1985; Hoeijmakers et al. 1987a,6; Van D uinei al. 1986; Vermeulen et al. 1986; Zwetsloot et al. 1986a,b) .
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MICROINJECTION EXPERIMENTS
The microinjection system Notwithstanding many attempts the establishment of a reliable mammalian in vitro repair system has not been a very rewarding enterprise. As an alternative we have developed an in vivo test system suitable for at least some of the factors involved in excision repair. This system utilizes living human (XP) fibroblasts as test-tubes in which repair components are introduced by microneedle injection (de Jonge et al. 1983 ). u.v.-induced unscheduled DNA synthesis (U D S) is used as a single cell parameter to determine the effect on the excision repair of the injected cells. This test-system has a wide range of possibilities and applications to the study of nucleotide excision.
(1) Crude protein extracts from various cells can be screened for the presence of proteins that transiently compensate for the defect in one of the XP complementation groups (see e.g. Fig. 1A ). On the basis of this property these polypeptides can then be isolated and characterized.
(2) As shown by Legerski et al. (1984) , microinjection of mRNA can, after in vivo translation into protein, also temporarily alleviate some of the XP deficiencies.
In principle this opens the possibility of isolating the responsible gene by cDNA cloning of the correcting RNA.
(3) Purified repair proteins from various prokaryotes and eukaryotes can be tested individually or in specific combinations for their effect on human excision repair or repair defects.
(4) The role of endogenous polypeptides that might be implicated in the excision pathway can be directly assessed in vivo by injection of (monoclonal) antibodies into human fibroblasts (e.g. monoclonal antibodies against DNA polymerase a).
(5) Finally, microinjection might be used to introduce certain repair substrates (in the form of D NA molecules carrying specific lesions) or inhibitors of specific steps in the excision process.
There are also obvious limitations inherent in the microinjection assay technique. Only a small number of samples can be tested in one experiment; it is a laborious, time-consuming procedure and yields only semi-quantitative results. We have concentrated mainly on the first and third application listed above and this section focusses on some of the results obtained thus far.
Injection of repair proteins of prokaryotes and eukaryotes into human fibroblasts
The effect of microinjection of defined prokaryotic proteins involved in excision repair on U D S of wild-type or XP fibroblasts of various complementation groups is summarized in Table 1 (for quantitative data see de Jonge et al. 1985) . Micrococcus luteus endonuclease and bacteriophage T 4 endonuclease V (which both catalyse the incision of damaged DNA at the site of cyclobutane dimers by a combined glycosylase and apyrimidinic endonuclease activity; Haseltine et al. 1980; Grafstrom et al. 1982) defects in XP, which was noted earlier for the T 4 enzyme by Tanaka et al. (1975 Tanaka et al. ( , 1977 and in the case of XPA-E and XP-F by Hayakawa et al. (1981) , indicates that these prokaryotic enzymes are able to act on pyrimidine lesions in mammalian chromatin and that the cellular repair machinery can recognize the resulting incision products and use them as substrates for repair synthesis. In contrast to the two u.v. endonucleases examined above, microinjection of the E. coli UvrABC and D proteins into XP-A, C and H fibroblasts did not result in restoration of u.v.-induced U D S (Table 1 ; Zwetsloot et al. 1986a) . The E. coli excinuclease was assayed under conditions in which a T 4 endonuclease preparation with the same in vitro incising activity was able to induce significant repair synthesis in the three XP complementation groups. T o exclude the possibility that the negative results with the E. coli proteins could be due to potential problems in transport of this bulky enzyme complex (total mass ~3 5 0 x 103M r, compared to 1 6 x l0 3M r for T4 endonuclease) through the nuclear membrane both endonucleases were also tested by direct microinjection into the nucleus of XP-A and C fibroblasts. The same results were obtained (see Table 1 ). Although various explanations of a negative result are possible (as discussed elsewhere; Zwetsloot et al. 1986a ) the most likely interpretation is that the/?. coli excinuclease does not act on D NA photoproducts in a mammalian chromatin context.
A different manner of removing dimer lesions induced by u.v. is exemplified by enzymic photoreactivation accomplished by a single protein: the photoreactivating enzyme (PRE). This flavoprotein binds specifically to dimers and after absorption of a quantum of the visible to near-u.v. spectrum it simply reverses the dimerization regenerating two unlinked pyrimidine bases. This reaction does not involve repair synthesis and can compete with the excision repair of cyclobutane dimers. To examine whether PRE is active on pyrimidine dimers in chromatin of mammalian cells purified photolyase from yeast was injected into repair-proficient fibroblasts. Since photoreactivation of these lesions should be at the expense of repair synthesis a reduction of the U D S level is expected in the injected cells if photoreactivation occurs. Fig. IB and Table 1 show that indeed a strong decrease in U D S of injected wild-type fibroblasts (to 20 % of non-injected control cells) was found. The fact that this reduction is photoreactivating light-dependent, proteinase ¡c-sensitive and not (Zwetsloot et al. 1985) . To determine whether lesions in X P cells also can be photoreactivated by the exogenous photolyase, the yeast protein was injected into fibroblasts from excision-deficient XP strains representing different complementation groups (all displaying more than 10% of the U D S of wild-type cells) and fibroblasts from two excision-proficient XP variant strains. In XP variant cells U D S was reduced to the same extent as in normal fibroblasts. Injected cells from XP complementation groups C, I and to a lesser extent XP-F also exhibited a reduced level of U D S (up to 50% of non-injected XP cells) indicating that pyrimidine dimers in these cells are accessible to and can be monomerized by the injected enzyme. In contrast, fibroblasts from groups A, D, E and H (with residual U D S activities up to 50% of wild-type cells) did not show any reduction in U D S upon PRE-injection and illumination with photoreactivating light (Zwetsloot et al. 19866 ). These findings strongly suggest that the photoproducts are not equally well accessible in both sets of XP complementation groups. In the latter XP dimers might be 'protected' against injected PRE by a defective repair complex. At present, we are characterizing CHO transformants containing the yeast and E. coli PRE genes inserted in a mammalian expression vector with the eventual aim of studying the long-term effects of selective dimer removal on survival, mutability and induction of chromosomal aberrations.
Purification and characterization ofXP correcting proteins
As mentioned above, crude extracts of human cells upon injection transiently compensate for the excision defect in XP fibroblasts. Table 2 shows that temporary correction is found for all excision-deficient XP complementation groups as indicated Table 2 . Levels of u.v.- 
induced UDS in homopolykaryons of various X P complementation groups after microinjection of human cell extracts U D S (grains/nucleus)')'
(% of wild-type ± s.e.m .)
Injected cell* Source extract* Non-injected Injected
XP4ROSV4Q (C) 14 ± 1 29 ± 2 *T h e X P complementation group is shown in parenthesis. f In each experiment the average number of grains per nucleus was calculated and expressed as % of the mean number of grains per nucleus of repair-competent fibroblasts (C5RO), assayed in parellel under the same conditions. For further details see Vermeulen et al. (1986) .
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by an increase in U D S. In the complementation groups examined extracts prepared from complementing XP (as well as normal) cells induce correction, in contrast to extracts from non-complementing XP fibroblasts. We conclude, therefore, that in each instance specific factors are responsible for the observed phenotypic correction. The data in Table 2 display a wide variation in the level of correction between different complementation groups. Undoubtedly, this reflects at least in part differences in concentration of the various correcting factors in the injected extract, particularly in those XP groups in which the correcting component is rate-limiting. Another factor that influences the level of U D S is the kinetics of complementation, which is found to vary between different complementation groups. Cell fusion and microinjection experiments have demonstrated that, e.g. the XP-A defect is fully corrected within 30min after introduction of the correcting factor (e.g. see Vermeulen et al. 1986 ). In contrast, complete compensation for the XP-C and D deficiencies is not achieved within 16-24 h after fusion with repair-competent fibroblasts (Giannelliei al. 1982; Keijzerei al. 1982) . Characterization of the XP-A and XP-G factors established that both of them are sensitive to proteolytic degradation, suggesting that they are proteins (de Jonge et al. 1983; Vermeulen et al. 1986 ). Both proteins were found to precipitate at between 25% and 40% (N H 4)2S 0 4 saturation. Testing of subsequent purification steps revealed that the XP-A correcting factor is retained on phosphocellulose and heparin columns and that it has high affinity for single-stranded D NA as well as u.v.-irradiated double stranded D N A attached to cellulose. A weaker affinity was found for non-irradiated double-stranded DNA (preliminary results). These findings support the idea that the XP-A correcting protein exerts its function in the nucleus presumably by involving binding to the u.v.-induced D NA lesions. At present, we are attempting large-scale purification of this polypeptide by a combination of the steps described above. Successful combinations of (NH4)2S 04 fractionation and phosphocellulose chromatography using a total HeLa cell extract, and phosphocellulose followed by u.v.-irradiated DNA-cellulose chromatography using a placenta extract have been achieved. However, one of the problems (in addition to the laborious assay procedure) is that the protein seems to be more labile upon further purification.
ISOLATION AND CHARACTERIZATION OF THE HUMAN REPAIR GENE ERC C -l

Isolation of human repair genes
Although simian virus 40 (SV40)-transformed XP fibroblasts seem to be the ideal source for the cloning of complementing excision repair genes they have thus far failed to yield genuine repair-proficient transformants upon genomic D NA trans fections (Lehmann, 1985) . In a number of laboratories, u.v.-resistant repaircompetent revertants have been obtained instead at a low frequency (e.g. see RoyerPokora & Haseltine, 1984) . The revertants probably arise in the course of longlasting selection protocols using low doses of u.v. light. We think that the reason for the failure to obtain genuine transformants originates at least in part from the fact 118 J . H. y. Hoeijmakers that X P cells (and also other human cells tested) are very restricted in the amount of D N A that becomes stably integrated in their genome after genomic D N A trans fection. This problem may be overlooked because the relative ease and high efficiency by which transformants containing dominant marker genes are obtained in certain XP cell lines suggests that gene transfer is very efficient. However, dominant marker genes are present in the transfected D NA in vast molar excess and they are in general very small (less than 2 kilobases (kb)), increasing the chance that the gene remains intact during the transfection process. Relying on the transfection efficiency of dominant markers alone is deceptive. We have found that on average a 20-to 100 fold smaller amount of exogenous D NA is present per human transformant compared with e.g. CHO, Ltk-and NIH 3T3 transformants (Hoeijmakers et al. 1987«) . It is, therefore, not surprising that to date most promising results have been obtained using CHO repair mutants induced in the laboratory. Transformants corrected by the uptake of human genes have been isolated for a number of excisiondeficient CHO complementation groups (Rubin et al. 1983; Maclnnes et al. 1984; Thompson et al. 1985 ; our unpublished results). The first human repair gene has been cloned using one such mutant (Westerveld et al. 1984 ) and more genes are on the way. The repair gene isolated was obtained by DNA-mediated gene transfer of the excision-deficient CHO mutant 43-3B (constructed by Wood & Burki, 1982) Daroudi, unpublished results). Although the human repair gene restores the full spectrum of impaired repair functions of 43-3 B, the complementation is not for all end-points to the wild-type level. In particular, u.v. and MM-C survival is generally lagging behind that of the parental line, even when multiple ERCC-1 gene copies are integrated in the 43-3B genome. This suggests that it is not due to a gene dose effect. A plausible explanation might be that the human gene product is unable to substitute fully for the CHO counterpart in the excision process. Screening of the Okayama/Berg (1983) cDNA library with genomic ERCC-1 probes resulted in the isolation of three cDNA clones, all of which appeared to be incomplete. However, by recombining different parts of each clone we succeeded in producing complete cDNA versions of the ERCC-1 transcript, which permitted analysis of the ERCC-1 gene structure and its gene product (van Duin et al. 1986 ).
Genes and proteins in human excision repair
Comparison of the cDNA sequence with the genomic DNA revealed that the gene is split over 10 exons. Sequence analysis of different cDNAs and nuclease Si digestion experiments indicated that one exon of 72 base-pairs (bp) (encoding an internal 24 amino acid portion of the predicted amino acid sequence of the ERCC-1 gene product) is alternatively spliced. Hence, the 1 -0-1 • 1 kb mRNA band, visible on Northern blots is in fact made up of two unresolved mRNA species, differing by 72 bp in size. To investigate the function of the two cDNAs, transfection exper iments were carried out to 43-3B cells. The cDNA derived from the larger transcript (pcDE) inserted into an Okayama/Berg (1983) mammalian expression vector was able to confer both u.v. and MM-C resistance on the mutant, in contrast to the cDNA of the small transcript (pcDE-72). Apparently, the presence of the 72bp exon is essential for the excision repair process. The function of the small RNA (if any) remains obscure. Using the Maxam & Gilbert (1980) sequencing technique the nucleotide sequences of both the 1098 and 1026 bp ERCC-1 cDNAs were deter mined and are presented in Fig. 2 Homology o/E R C C -1 gene products with other polypeptides
T o obtain information on the role of ERCC-1 in excision repair the deduced ERCC-1 amino acid sequence was compared with those of other proteins and functional protein domains to search for homology. Within the class of repair polypeptides extensive amino acid homology was detected with the yeast excision repair protein RADIO, which is predicted to have a size of 210 amino acid residues The arrowhead points to the arginine residu that by homology with other ADP-ribosylation sites is suggested to be the actual site for mono-ADP-ribosylation, e.g. by cholera toxin (see Hoeijmakers et al. 19876, for details) . Asterisk, stop codon. Interrupted under lining, polyadenylation signal. (Reynolds et al. 1985a) . T he level of sequence identity is highest between the Cterminal half of RADIO and the middle 120 amino acids of ERCC-1 (34% identity).
However, detectable homology exists also in the N-terminal parts of both proteins (Fig. 3) . T h is finding supports the idea that ERCC-1 and RADIO are descendants of the same primordial gene and that they fulfil similar functions. The apparent C- Amino-acid sequence homology between ERCC-1, RADIO and part of uvrA 
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In addition to homology with RADIO, computer analysis indicated the existence of a 42 amino acid homologous region between ERCC-1 and uvrA (31% identity) (Fig. 3) . In ERCC-1 this stretch includes the point where the alignment with RADIO stops. If this region represents a functional domain shared by uvrA and ERCC-1 it is remarkable that it is only for the first part present in RADIO, since uvrA and ERCC-1 are from such distant organisms and RADIO should be closer to both of them.
Further analysis has to be done to clarify the significance of this observation.
A search for homology of ERCC-1 amino acid sequences with identified functional protein domains revealed homology with nuclear location signals (N L S ), D NA binding domains (helix-turn-helix motive) and adenosine phosphate (ADP) ribosylation sites found in other polypeptides. The position of these tentative functional domains in ERCC-1 is indicated in Fig. 2 . Details on the amino acid sequence comparisons have been published elsewhere (Hoeijmakers et al. 1987b) . The N L S is situated in the N terminus of the ERCC-1 protein and suggests that the ERCC-1 gene product is actively transported into the nucleus. Transfection exper iments with a ERCC-1 cDNA clone lacking the first 53 amino acids have shown that this part of the ERCC-1 protein, which includes the tentatively identified N L S , is not essential for correction of the 43-3 B cells (Van Duin et al. 1986 ). It is possible that passive diffusion of the protein through the nuclear pore complex is sufficient to allow the transformants to survive our u.v. and MM-C selection conditions. Alternatively, the ERCC-1 protein molecules might take the opportunity to reach (and possibly bind to) the D NA when the nuclear membrane is temporarily absent during mitosis. The proposed D NA binding property of ERCC-1 could be relevant in this respect. The potential D N A binding domain is located in the middle part of ERCC-1. It coincides with the region that exhibits the highest level of sequence conservation with RADIO (Van Duin et al. 1986 ). Finally, the tentative ADP ribosylation site is located in the C-terminal portion. Intriguingly, it is positioned precisely at the border between exon 7 and the alternatively spliced exon 8. Transcripts lacking this exon would specify a gene product that lacks amino acid sequences thought to be essential for the ADP-ribosyl acceptor function. Although this and the other suggested properties of the ERCC-1 gene product(s) are not unexpected for repair proteins, definite proof awaits experiments with the isolated protein. Production and purification of the ERCC-1 protein(s) therefore have a high priority in our research programme, as well as the isolation of additional repair genes. It is hoped that this will lead to a detailed understanding of the mechanism of excision repair in higher organisms, as in E. coli.
